...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: Impact factors

First, impact factors are NOT a quality metric, they are simply a measure of citation frequencyl. 

Scond, before anyone has had some Fear, Uncertainty or Doubt about the quality of the research by RVX, the RVX208-publication in Atherosclerosis received the following analysis - where the Atherosclerosis paper is said to be extremely highly cited (=high impact as per the impact factor definition).


"This publication in Atherosclerosis has been cited 36 times. 94% of its citations have been received in the past two years, which is higher than you might expect, suggesting that it is currently receiving a lot of interest.

Compared to other publications in the same field, this publication is extremely highly cited and has received approximately 12 times more citations than average."


New Message
Please login to post a reply